Abstract P6-11-16: PYTHIA: A phase II study of palbociclib plus fulvestrant versus placebo plus fulvestrant for pretreated patients with ER+/HER2- metastatic breast cancer

Authors :: P Flamen
Theodora Goulioti
Meredith M. Regan
Dimitrios Zardavas
Barbara Ruepp
A. Hiltbrunner
Luca Malorni
L. Blacher
M.J. Piccart
Rudolf Maibach
R. D. Gelber
Source :: Cancer Research. 77:P6-11
Publication Year :: 2017
Publisher :: American Association for Cancer Research (AACR), 2017.
Abstract: This abstract was not presented at the symposium.

Subjects :: Gynecology
Oncology
Cancer Research
medicine.medical_specialty
Fulvestrant
business.industry
Phases of clinical research
Palbociclib
Placebo
medicine.disease
Metastatic breast cancer
Internal medicine
medicine
business
medicine.drug

Tools